)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Curaleaf
Curaleaf (CURA) investor relations material
Curaleaf Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary3 Nov, 2026
Executive summary
Q3 revenue reached a record $352.7M, up 10.9% YoY and 3.6% sequentially; adjusted EBITDA was $77.6M at a 22.0% margin.
Domestic and international revenue grew 8% and 28%, respectively; quarter-end cash was $104.9M.
Priorities included improving cultivation yields, product quality and consistency, supply-chain efficiency, and disciplined inventory management.
Financial highlights
Q3 revenue was $352.7M versus $317.9M a year earlier; gross profit was $170.5M.
Adjusted EBITDA was $77.6M, up from $71.7M in Q3 2025; net loss from continuing operations was $37.4M, or $0.14 per share, versus $54.3M, or $0.24 per share.
Retail revenue was $243M and wholesale revenue was $106M, representing 70% and 30% of retail and wholesale revenue, respectively.
Nine-month revenue was $1,017.0M, up 9% YoY; continuing-operations net income was $45.2M versus a $152.4M loss.
Outlook and guidance
Q4 revenue is expected to rise 1%–2% sequentially, implying ~$358M at the midpoint; German pricing pressure and seasonal promotions temper the outlook.
Q4 adjusted gross margin is expected at 48%–49%, with adjusted EBITDA roughly flat with Q3; SG&A savings are expected to offset some margin compression.
FY 2026 operating cash flow target remains ~$150M; FY capex is expected to be ~$80M.
Spain commercialization is expected in Q4 2026; France and Turkey market launches are anticipated in 2027, subject to regulatory processes.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Curaleaf
- Aurora shareholders are offered up to a 51% premium and entry into a global cannabis leader’s growth.CURA
Investor update - Q2 2026 revenue up 10% to $340M, net income $12.5M, 21% EBITDA margin, strong global growth.CURAQ2 2026
- All resolutions, including U.S. continuation and board elections, were approved without dissent.CURAAGM 2026
- Q1 2026 revenue rose 6% to $324M, with $70M net income and strong global expansion.CURAQ1 2026
- Q4 2025 revenue hit $333M, margins improved, and international revenue grew 65% year-over-year.CURAQ4 2025
- Q3 revenue hit $320M, with 56% international growth and improved margins despite price pressure.CURAQ3 2025
- Q3 saw $331M revenue, 49% gross margin, and 82% international growth amid U.S. headwinds.CURAQ3 2024
- Q2 revenue up 2% to $342M, with 78% international growth and 48% adjusted gross margin.CURAQ2 2024
- Board size set at 10, all directors and auditor approved, with no questions from shareholders.CURAAGM 2024
Next Curaleaf earnings date
Q4 202625 Feb, 2027
Curaleaf
Next Curaleaf earnings date
Q4 202625 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Curaleaf Holdings Inc is a U.S.-based cannabis company that cultivates, processes, and distributes cannabis products for medical and adult-use markets. The company offers flower, extracts, edibles, and topicals through its network of dispensaries and wholesale channels. It operates across multiple U.S. states under several brands. Curaleaf Holdings Inc is headquartered in Wakefield, Massachusetts, and its shares are listed on the CSE.